We aimed to assess the relationship between residual pulmonary vascular obstruction
(RPVO) on planar lung scan after completion of at least 3 months of anticoagulant therapy …

In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …

Background Cancer‐associated venous thromboembolism (VTE) carries a high rate of
recurrence and death. Guidelines recommend continued anticoagulation therapy as long as …

Venous thromboembolism, occlusion of dialysis catheters, circuit thrombosis in
extracorporeal membrane oxygenation (ECMO) devices, acute limb ischemia, and isolated …

Acute pulmonary embolism (PE) is a relatively common form of venous thromboembolism
that can lead to significant morbidity and mortality, with additional legal liability for …

Background Improvements in availability and accuracy of diagnostic testing in pulmonary
embolism (PE) in the last 20 years have more recently been paralleled by the introduction of …

For most patients, direct oral anticoagulants (DOACs) are preferred over vitamin K
antagonists for stroke prevention in atrial fibrillation and for venous thromboembolism …

Objective To evaluate efficacy and safety of oral anticoagulant regimens and aspirin for
extended venous thromboembolism (VTE) treatment. Methods We searched MEDLINE …

Venous thromboembolism (VTE) is a significant public health burden. Management of
anticoagulation is the mainstay of treatment for the vast majority of patients. The introduction …

Anticoagulation therapy is the first line and drug of choice for both the treatment and
prophylaxis of venous thromboembolism (deep vein thrombosis and/or pulmonary …